CO-CSG
23.1.2024 14:31:29 CET | Business Wire | Press release
Communication service providers (CSPs) are racing to modernize their operations and deliver dynamic and personalized experiences for their customers. To leverage automation, intelligence and orchestration, they’re working to improve the customer experience across all touchpoints. In 2023, CSG® (NASDAQ: CSGS)’s award-winning solutions and integrated omnichannel approach helped global brands transform their customer experience, earning CSG recognition from leading analyst firms Gartner, Frost & Sullivan, Kaleido Intelligence, MGI and Quadrant Knowledge Solutions.
In recent months, CSG has been recognized as:
-
A Niche player in the 2023 Gartner® Magic Quadrant™ for Configure, Price and Quote Application Suites
- CSG Quote & Order enables CSPs to configure products with live pricing, creating comprehensive orders that seamlessly flow from quotes to fulfillment. An API-powered CPQ solution built for complex B2B services, it provides CSPs with the composability and order management capabilities they need to drive faster time to revenue and deliver a better overall customer experience.
-
A Leader in the 2023 Frost Radar for 5G Revenue Management and Monetization
- CSG enables CSPs to reduce reliance on multi-vendor solutions, lowering time to market and total cost of ownership by integrating charging, billing, policy control and interconnect. The depth of its capability portfolio, modular SaaS platforms and unique partnership-driven approach earn CSG a leadership placement for its ability to monetize a variety of 5G use cases on a single SaaS platform.
- Frost & Sullivan writes: "CSG has proven how it can integrate assets from a network and a messaging portfolio to provide a one-stop shop for CSPs. The company has mastered the challenges of hybrid operations."
-
A Leader in the 2023 MGI 360 Rating: The Agile Billing Top 50 Buyers Guide
- MGI recognized CSG Ascendon as “a good fit for organizations looking to create modern monetization capability to support new business initiatives”. The report states: "CSG Ascendon represents a multi-tenant SaaS approach to monetization tools for B2C-oriented digital services. It has a sophisticated product catalog capability, can support customer and product hierarchies and abstract complex pricing methods, including usage."
-
A Champion in the 2023 Kaleido Intelligence Roaming Vendor Hub – Clearing & Settlement
- CSG Retail Roaming Management platform enables CSPs to build new dynamic digital wholesale services and to drive the associated business models over 4G and 5G networks of any size. Kaleido notes: The CSG platform is "agile and extensible, bringing significant new functionality with minimal disruption to existing infrastructure."
- CSG was also recognized as a High-Flyer in the Roaming Analytics & VAS and Fraud Management rating categories.
-
A Leader in the 2023 SPARK Matrix: Configure, Price & Quote
- CSG Quote & Order helps service providers deliver complex digital offerings by addressing the dual challenges of B2B2X relationships with customers and partners. Its comprehensive capabilities, impressive customer references, well-defined roadmap and vision and a highly scalable product suit earn CSG strong ratings for technological excellence and customer impact.
- Quadrant Knowledge Solutions notes: "CSG offers a leading CPQ portfolio, customized specifically for the telecom industry, apart from also having strong third-party partnerships, robust functional capabilities and an extensive customer base."
Beyond these recognitions, CSG is mentioned in the 2023 Gartner Market Guide for CSP Customer Management and Experience Solutions, which CIOs can use to shape their sourcing strategy by understanding the investments and directions of representative vendors. CSG was also mentioned in the 2022 Gartner Market Guide for Revenue Management and Monetization as one of 20 vendors providing a wide variety of solutions, offering different portfolios, deployment/implementation approaches and focus areas for various segments of CSPs.
“Global operators trust CSG to modernize their business because we've demonstrated time and again that we understand their customers’ needs and provide the capabilities they need to drive tangible growth,” said Chad Dunavant, Chief Product & Strategy Officer, CSG. “The breadth and depth of our portfolio support CSPs regardless of their focus on B2C, B2B or B2B2X as we empower them to deliver new services faster than competitors, increase customer satisfaction and boost brand loyalty. This has been our bread and butter for 40+ years and is why industry analysts consistently rank CSG among the leading BSS solution providers across the industry.”
For more information about CSG, visit www.csgi.com.
Gartner, Magic Quadrant for Configure, Price and Quote Application Suites, Mark Lewis, Dayna Radbill, 11 December 2023.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
Gartner and Magic Quadrant are registered trademarks of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.
About CSG
CSG empowers companies to build unforgettable experiences, making it easier for people and businesses to connect with, use and pay for the services they value most. Our customer experience, billing and payments solutions help companies of any size make money and make a difference. With our SaaS solutions, company leaders can take control of their future and tap into guidance along the way from our fiercely committed and forward-thinking CSGers around the world.
Want to be future-ready and a change-maker like the global brands that trust CSG? Visit csgi.com to learn more.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240123732657/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
